Harrow Health

Harrow Health, formerly known as Imprimis Pharmaceuticals, is a publicly traded pharmaceutical company (Nasdaq: HROW) based in Nashville, TN.

Harrow Health, Inc.
FormerlyImprimis Pharmaceuticals ( - Jan 2019)
Company typePublic
Traded as
Nasdaq: HROW
Russell Microcap Index component
IndustryPharmaceutical Industry
Founded2012 (2012)
Headquarters
Nashville, TN
,
United States
Number of locations
1 (Nashville, TN)
Key people
  • Mark L. Baum (CEO)
  • Andrew R. Boll (CFO)
ProductsPharmaceuticals
Subsidiaries
  • ImprimisRx
  • Eton Pharmaceuticals
  • Surface Pharmaceuticals
  • Melt Pharmaceuticals
  • Visionology.com
Websitewww.harrow.com 

Since 2014, Harrow has started six healthcare businesses, including ImprimisRx, an ophthalmic-focused pharmaceutical company. In 2017, Harrow started and funded Eton Pharmaceuticals with a $20 million Series A financing, and Eton is now a publicly traded company. In 2017, Harrow started Surface Pharmaceuticals, hiring Dr. Kamran Hosseini to be its chief executive officer. Surface was funded with a $20 million Series A financing with Flying L Partners leading the round. In 2018, Harrow started Melt Pharmaceuticals and announced an $11 million Series A financing.

In 2019, Harrow hired founder and former CEO of Doxy.me, Drew Livingston, as its Chief Innovation Officer. Livingston is the senior executive of Harrow's Visionology.com telemedicine subsidiary.

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.